We're recruiting a new Chair of Obesity Management Collaborative- UK (OMC-UK)
We are seeking an experienced and respected leader with a strong background in obesity care or a related healthcare or academic field. You will bring:
News
Proposed referral criteria for Specialist Weight Management Services in England
This joint position statement was produced in June 2025 by the Society for Endocrinology and Obesity Management Collaborative UK in collaboration with The Association for the Study of Obesity, Royal College of Physicians, NHS England, British Obesity & Metabolic Surgery Society, and All About Obesity.
Category
Tirzepatide has been approved for use on the NHS in Scotland
Tirzepatide (Mounjaro®) is accepted for restricted use within NHS Scotland by the SMC.
Category
NICE has issued draft recommendations for the use of Mounjaro as a treatment for overweight or obesity
As of June 2024, the National Institute for Health and Care Excellence (NICE) has issued draft recommendations the use of Mounjaro as a treatment for overweight or obesity.
Category
Guidance for the phased introduction of new medical therapies for weight management
A joint position statement by the Society for Endocrinology and Obesity Management Collaborative UK
This position statement is aimed at healthcare professionals working within weight management services, organisations delivering medical therapies for patients living with obesity, and commissioners of such services. Its objectives are to:
Category
Semaglutide and the future of obesity care in the UK
Published in The Lancet, in June 2023, read this publication on the future of obesity care in the UK.